DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control (Q24296626)

intrinsic apoptotic signaling pathway

GOA release 2020-03-11

1 reference

GOA release 2020-03-11

hepatocellular carcinoma

1 reference

1 reference

P-C Chang

1

0 references

C-W Chi

2

0 references

G-Y Chau

3

0 references

F-Y Li

4

0 references

Y-H Tsai

5

0 references

J-C Wu

6

0 references

Y-H Wu Lee

7

0 references

language of work or name

English

0 references

publication date

30 March 2006

0 references

number of pages

13

1 reference

SUMO in cancer--wrestlers wanted

inferred from page(s)

published in

Oncogene

0 references

volume

25

0 references

issue

14

0 references

page(s)

1991-2003

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Chromosome aberrations in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: old and new paradigms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Genetics of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Cancer epidemiology and control in Taiwan: a brief review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Hepatocellular carcinoma: recent trends in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Minireview: Cyclin D1: normal and abnormal functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Overexpression of a DEAD box protein (DDX1) in neuroblastoma and retinoblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

MicroRNA biogenesis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Diverse cellular transformation capability of overexpressed genes in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Overexpression of tumour suppressor retinoblastoma 2 protein (pRb2/p130) in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

p68 DEAD box RNA helicase expression in keratinocytes. Regulation, nucleolar localization, and functional connection to proliferation and vascular endothelial growth factor gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Amplification of c-myc in hepatocellular carcinoma: correlation with clinicopathologic features, proliferative activity and p53 overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Functional coherence of the human Y chromosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Hepatitis B virus X protein represses E-cadherin expression via activation of DNA methyltransferase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Pathogenesis of hepatitis C-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

21 January 2018

Birth of the D-E-A-D box

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

The protein family of RNA helicases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Genetic and epigenetic alterations as hallmarks of the intricate road to cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Hepatitis C virus core protein binds to a DEAD box RNA helicase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Downregulation of stomach cancer-associated protein tyrosine phosphatase-1 (SAP-1) in advanced human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Overexpression of rck/p54, a DEAD box protein, in human colorectal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Hepatitis C virus core protein interacts with a human DEAD box protein DDX3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3-->p11.23

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Estimating the world cancer burden: Globocan 2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Cancer burden in the year 2000. The global picture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

p21/WAF1, p53 and PCNA expression and p53 mutation status in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

DEAD-box proteins: the driving forces behind RNA metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Hepatitis C virus infection is associated with the development of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Tumor viruses and cell signaling pathways: deubiquitination versus ubiquitination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Reduced p21(WAF1/CIP1) protein expression is predominantly related to altered p53 in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Expression of the 'dead box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Liver pathology in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

LFIRE-1/HFREP-1, a liver-specific gene, is frequently downregulated and has growth suppressor activity in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Environmental factors and risk for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Expression of c-Myc, c-Fos, and c-jun in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

Comprehensive proteomic analysis of the human spliceosome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Correlation between p21(waf1) and p16(INK4a) expression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Decreased expression and rare somatic mutation of the CIP1/WAF1 gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Reduced p21(WAF1/CIP1) expression and p53 mutation in hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Loss of p16(INK4) protein, alone and together with loss of retinoblastoma protein, correlate with hepatocellular carcinoma progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Cyclin D1 overexpression in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Telomerase expression and p53 status in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Expression of MAGE, GAGE and BAGE genes in human liver diseases: utility as molecular markers for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Reduced messenger RNA expression level ofp21CIP1 in human colorectal carcinoma tissues and its association withp53 gene mutation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Point mutation, allelic loss and increased methylation of c-Ha-Ras gene in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Association of cyclin D1 expression with factors correlated with tumor progression in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Decreased expression of p27 protein is associated with advanced tumor stage in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Increase in primary liver cancer in the UK, 1979-94

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Expression of p21(WAF1) and p53 and polymorphism of p21(WAF1) gene in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021

Expression of transforming growth factor-alpha and hepatitis B surface antigen in human hepatocellular carcinoma tissues and its significance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209239

7 January 2021